Vice-President, Neuroscience

Dr. Cyril De Colle brings 12 years of research and development experience for CNS diseases at major pharmaceutical and biotechnology companies: Parke-Davis (now Pfizer), Roche Pharmaceuticals and Amgen Inc. More recently, Dr. De Colle strengthened his expertise in clinical research at Jazz Pharmaceuticals, a specialized biotechnology company focusing on the development of pharmaceutical products for neurology and psychiatry indications. At Jazz Pharmaceuticals Dr. De Colle served as the clinical lead for neurology indications.

Dr. De Colle received degrees in physiology and pharmacology and received his Ph.D. in neuroscience from the University of Montpellier, France in 2000.